Overview

Detect motility disorders

Impedance planimetry testing with Endoflip™ 300 provides real-time measurements of the pressure and dimensions of the esophagus during endoscopic evaluation and surgical procedures.1 Impedance planimetry testing with Endoflip™ 300 is a well-tolerated, convenient way to assess esophageal motility that can inform the need to refer patients to high-resolution manometry.2,3 During surgical procedure, impedance planimetry testing with Endoflip™ 300 gives real-time feedback that can reduce negative outcomes of procedures like Nissen fundoplication, Heller myotomy, and per-oral endoscopic myotomies.4–6

Evaluate motility, minimize discomfort1

Measure pressure and dimensions in the esophagus, pylorus, and anal sphincters with a patient‑friendly solution.

View Technical Info Sheet

You need an objective means to help you diagnose GERD and motility disorders​

There are many types of motility disorders, and pinpointing the underlying cause of the patients symptoms can be challenging.10

Impedance planimetry testing with Endoflip™ 300 can provide information to aid in therapeutic decision making.11

How does Endoflip™ technology work?

Endoflip™ technology uses high-resolution impedance planimetry to measure luminal geometry and pressure during volume-controlled distension. It helps you assess the mechanical properties of the esophageal wall and opening dynamics of the gastroesophageal junction in various esophageal diseases.​

Our product portfolio 

Endoflip™ 300 impedance planimetry system

Endoflip™ 300 uses a balloon catheter to display diameter estimates of the measurement area in real-time. It can measure and display diameter estimates at up to 16 points within the balloon. 

Endoflip™ 300 helps identify motility disorders by providing real-time pressure and dimension measurements in the esophagus, pylorus, and anal sphincters. 

Endoflip™ 300 provides real-time assessment of the lower esophageal sphincter (LES) myotomy during Heller myotomy or per-oral endoscopic myotomy (POEM) procedures.12

Endoflip™ measurement catheter

The Endoflip™ EF-322N and EF-325N measurement catheters are designed for use with the Endoflip™ impedance planimetry system. They have integrated pressure sensors for balloon pressure measurement.

Esoflip™ dilation catheter

The Esoflip™ ES-310 and ES-320 balloon catheters are indicated for use to dilate esophageal strictures due to esophageal surgery, primary gastroesophageal reflux, or radiation therapy.

The Esoflip™ ES-330 balloon catheter is used in a clinical setting to dilate the gastroesophageal junction (EGJ) to treat achalasia.

The Esoflip™ ES-310 catheter is not suitable for diameter measurements and dilation of strictures smaller than 6 mm or greater than 10 mm.

The Esoflip™ ES-320 catheter is not suitable for diameter measurements and dilation of strictures smaller than 8 mm or greater than 20 mm.

The Esoflip™ ES-330 catheter is not suitable for diameter measurements and dilation of strictures smaller than 8 mm or greater than 30 mm.

Order Information
ORDER CODE DESCRIPTION UNIT OF MEASURE QUANTITY
EF-300 Endoflip™ impedance planimetry system Each 1
EF-322N Endoflip™ measurement catheter 16 cm Each 1
EF-325N Endoflip™ measurement catheter 8 cm Each 1
ES-320 Esoflip™ dilation catheter 20 mm Box 1 boîte de 5
ES-330 Esoflip™ dilation catheter 30 mm Box 1 boîte de 5
Order Information
ORDER CODE DESCRIPTION UNIT OF MEASURE QUANTITY
EF-300 Endoflip™ impedance planimetry system Each 1
EF-322N Endoflip™ measurement catheter 16 cm Each 1
EF-325N Endoflip™ measurement catheter 8 cm Each 1
ES-320 Esoflip™ dilation catheter 20 mm Box 1 boîte de 5
ES-330 Esoflip™ dilation catheter 30 mm Box 1 boîte de 5

Risk information:

Arrhythmia, anaphylaxis, aspiration/inhalation, bacterial infection, bleeding/hemorrhage, death (for Esoflip procedures only), delay to treatment/therapy, dental trauma, dysphagia, gastrointestinal regurgitation (for Esoflip procedures only), heartburn/indigestion (for Esoflip procedures only), hypersensitivity/allergic reaction, laceration of the esophagus, misdiagnosis/misclassification, pain, perforation of the esophagus, thermal burn, vasovagal response.

 

The material on this website should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s).
Please note that the intended use of a product may vary depending on geographical approvals.
See the device manual(s) for detailed information regarding the intended use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events.
For an MRI compatible device(s), consult the MRI information in the device manual(s) before performing an MRI.
If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website manuals.medtronic.com.
Manuals can be viewed using a current version of any major internet  browser. For best results, use Adobe Acrobat® Reader with the browser.
Medtronic products placed on European markets comply with EU and UK legislation (if applicable) on medical devices.
For any further information, contact your local Medtronic representative and/or consult the Medtronic website.

  • 1. Endoflip™ 300 Platform Operator's Manual.

  • 2. Carlson, Dustin A., et al. "Esophageal motility classification can be established at the time of endoscopy: a study evaluating real-time functional luminal imaging probe panometry." Gastrointestinal endoscopy 90.6 (2019): 915–923.

  • 3. Farina, Domenico A., and Dustin A. Carlson. "Functional Luminal Imaging Probe (FLIP) as an Adjunctive Modality in Evaluation of Esophageal Dysmotility." Foregut 1.3 (2021): 286–295.

  • 4. Ilczyszyn A, Botha A. Feasibility of esophagogastric junction distensibility measurement during Nissen fundoplication. Dis Esophagus. 2014 Sep-Oct;27(7):637–44.

  • 5. Carlson, Dustin A. "Evaluation of esophageal motility during endoscopy with the functional luminal imaging probe." Techniques in Gastrointestinal Endoscopy 20.3 (2018): 107–113.

  • 6. Hirano, Ikuo, John E. Pandolfino, and Guy E. Boeckxstaens. "Functional lumen imaging probe for the management of esophageal disorders: expert review from the clinical practice updates committee of the AGA institute." Clinical Gastroenterology and Hepatology 15.3 (2017): 325–334.

  • 7. Muthusamy VR, Lightdale JR, Acosta RD, et al. The role of endoscopy in the management of GERD. Gastrointestinal Endoscopy. 2015;81(6):1305-1310. doi: 10.1016/j.gie.2015.02.021. ​

  • 8. Herregods, T. V. K., et al. Patients with refractory reflux symptoms often do not have GERD. Neurogastroenterology & Motility. 2015;27(9):1267-1273.​

  • 9. Vakil, N. Prescribing proton pump inhibitors: is it time to pause and rethink? Drugs. 2012; 72, (4): 437–445 (72):438.​

  • 10. Chaudhury A, Mashimo H. Oropharyngeal & esophageal motility disorders. Current diagnosis & treatment: gastroenterology, hepatology and endoscopy. 2016;3:164.​

  • 11. Ahuja NK, Agnihotri A, Lynch KL. Esophageal distensibility measurement: impact on clinical management and procedure length. Dis Esophagus. 2017 Aug 1;30(8):1–8.

  • 12.  Su B, Dunst C, Gould J, et al. Experience-based expert consensus on the intra-operative usage of the Endoflip impedance planimetry system. Surgical Endoscopy: And Other Interventional Techniques. 2021;35(6):2731-2742. doi:10.1007/s00464-020-07704-3.